Cargando…
Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
BACKGROUND: The pathobiology of heart failure with preserved ejection fraction (HFpEF) is still poorly understood, and effective therapies remain limited. Diabetes and mineralocorticoid excess are common and important pathophysiological factors that may synergistically promote HFpEF. The authors aim...
Autores principales: | Hegyi, Bence, Mira Hernandez, Juliana, Ko, Christopher Y., Hong, Junyoung, Shen, Erin Y., Spencer, Emily R., Smoliarchuk, Daria, Navedo, Manuel F., Bers, Donald M., Bossuyt, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851441/ https://www.ncbi.nlm.nih.gov/pubmed/36416174 http://dx.doi.org/10.1161/JAHA.122.027164 |
Ejemplares similares
-
Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
por: McDiarmid, Adam K., et al.
Publicado: (2019) -
Cardiomyocyte Na(+) and Ca(2+) mishandling drives vicious cycle involving CaMKII, ROS, and ryanodine receptors
por: Hegyi, Bence, et al.
Publicado: (2021) -
Evaluation of aldosterone antagonist utilization in heart failure with reduced and preserved ejection fraction at an academic medical center
por: Bradley, Daniel, et al.
Publicado: (2019) -
Nitrosylation of cardiac CaMKII at Cys290 mediates mechanical afterload‐induced increases in Ca(2+) transient and Ca(2+) sparks
por: Alim, Chidera C., et al.
Publicado: (2022) -
Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure
por: Bossuyt, Julie, et al.
Publicado: (2022)